Literature DB >> 1508295

Acetylcholinesterase-rich pyramidal neurons in Alzheimer's disease.

S Heckers1, C Geula, M M Mesulam.   

Abstract

The distribution of acetylcholinesterase (AChE)-rich pyramidal neurons was studied in the cortices of 7 Alzheimer's Disease (AD) patients and 4 normal-aged subjects. Both groups showed a characteristic distribution of these neurons with the highest density in motor and premotor areas, moderate density in association cortices, and low density in limbic-paralimbic areas. Three areas (Brodmann areas 6,22, and 24) were chosen for quantitative analysis. The number of pyramidal neurons that display an AChE-rich staining pattern was significantly reduced in AD patients. Nerve cell density was not significantly different in adjacent Nissl-stained sections. The density of AChE-rich (cholinergic) fibers was also decreased in all three cortical areas of the AD patients but was not correlated with the number of AChE-rich neurons. Loss of AChE-rich neurons was more pronounced in areas with high counts of tangles. These findings show that layer 3 and 5 pyramidal neurons in AD display a reduction of AChE activity. This phenomenon can not be attributed to the well known loss of cortical neurons or cholinergic innervation in AD.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1508295     DOI: 10.1016/0197-4580(92)90072-6

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  11 in total

1.  Immunohistochemical analysis of hippocampal butyrylcholinesterase: Implications for regional vulnerability in Alzheimer's disease.

Authors:  Katsuyoshi Mizukami; Hiroyasu Akatsu; Eric E Abrahamson; Zhiping Mi; Milos D Ikonomovic
Journal:  Neuropathology       Date:  2015-08-21       Impact factor: 1.906

2.  Brain acetylcholinesterase promotes amyloid-beta-peptide aggregation but does not hydrolyze amyloid precursor protein peptides.

Authors:  E O Campos; A Alvarez; N C Inestrosa
Journal:  Neurochem Res       Date:  1998-02       Impact factor: 3.996

Review 3.  Cholinergic circuitry of the human nucleus basalis and its fate in Alzheimer's disease.

Authors:  M-Marsel Mesulam
Journal:  J Comp Neurol       Date:  2013-12-15       Impact factor: 3.215

4.  Frontal and periventricular brain white matter lesions and cortical deafferentation of cholinergic and other neuromodulatory axonal projections.

Authors:  N I Bohnen; C W Bogan; M L T M Müller
Journal:  Eur Neurol J       Date:  2009-09

5.  Cholinesterase inhibitors affect brain potentials in amnestic mild cognitive impairment.

Authors:  Rie Irimajiri; Henry J Michalewski; Edward J Golob; Arnold Starr
Journal:  Brain Res       Date:  2007-02-02       Impact factor: 3.252

Review 6.  Imaging of cholinergic and monoaminergic neurochemical changes in neurodegenerative disorders.

Authors:  Nicolaas I Bohnen; Kirk A Frey
Journal:  Mol Imaging Biol       Date:  2007 Jul-Aug       Impact factor: 3.488

Review 7.  The cholinergic system and Parkinson disease.

Authors:  Nicolaas I Bohnen; Roger L Albin
Journal:  Behav Brain Res       Date:  2010-01-07       Impact factor: 3.332

8.  Cortical and striatal neurone number in Huntington's disease.

Authors:  H Heinsen; M Strik; M Bauer; K Luther; G Ulmar; D Gangnus; G Jungkunz; W Eisenmenger; M Götz
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

9.  Heterogeneity of cholinergic denervation in Parkinson's disease without dementia.

Authors:  Nicolaas I Bohnen; Martijn L T M Müller; Vikas Kotagal; Robert A Koeppe; Michael R Kilbourn; Sid Gilman; Roger L Albin; Kirk A Frey
Journal:  J Cereb Blood Flow Metab       Date:  2012-05-09       Impact factor: 6.200

10.  Revisiting the Role of Acetylcholinesterase in Alzheimer's Disease: Cross-Talk with P-tau and β-Amyloid.

Authors:  María-Salud García-Ayllón; David H Small; Jesús Avila; Javier Sáez-Valero
Journal:  Front Mol Neurosci       Date:  2011-09-13       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.